Often times, there is much more at play than the old adage of the American Medical Field calories in, calories out. Recognizing that inflammation and metabolic dysfunction lie at the heart of nearly all conditions from Autoimmunity to Type 2 Diabetes, PCOS, infertility, and even cognitive decline, an integrative and well rounded approach to treatment in 2024 is paramount, not optional
doi: 10.1210/en.2009-0283
This triple-agonist approach targets GLP-1, GIP, and glucagon receptors, creating a synergistic effect that produces weight loss results exceeding anything previously achieved in clinical trials
Appetite changes often occur quite rapidly
Both medicines are unlicensed in the UK, meaning they cannot be prescribed through standard NHS or private prescribing routes